Irvine Scientific Introduces Chemically-Defined Dendritic Cell Culture Medium for Immunotherapy Applications
Dendritic cells are a key contributor to developing cancer vaccines SANTA ANA, California – September 19, 2017: Irvine Scientific, a world leader in cell culture media development and manufacture, today announced the introduction of PRIME-XV® Dendritic Cell Maturation CDM, a chemically-defined, animal component-free medium for the differentiation of monocytes into immature dendritic cells, and subsequent maturation in... Read more